Tidemark LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Tidemark LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 119 shares of the company’s stock, valued at approximately $36,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. MML Investors Services LLC boosted its stake in HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP purchased a new position in HCA Healthcare in the 3rd quarter worth approximately $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $18,044,000. Alpha DNA Investment Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at $869,000. Finally, NRI Wealth Management LC bought a new stake in HCA Healthcare in the 4th quarter worth about $2,896,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $319.82 on Monday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $78.74 billion, a price-to-earnings ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock’s 50 day simple moving average is $319.00 and its two-hundred day simple moving average is $344.95.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company posted $5.90 earnings per share. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.90%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HCA. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada dropped their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Barclays decreased their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.